Imunon : Management Change/Compensation - Form 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of...
Source: marketscreener.com
Wave Life Sciences Nasdaq News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Wave Life Sciences Nasdaq. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Wave Life Sciences Nasdaq Today - Breaking & Trending Today
Wave Life Sciences First Quarter 2024 Financial Results Scheduled for May 9, 2024
CAMBRIDGE, Mass., May 02, 2024 -- Wave Life Sciences Ltd. , a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, will host a...
Source: marketscreener.com
Wave Life Sciences Announces Approval of First Clinical Trial Application for RestorAATion-2 Trial of WVE-006 in Individuals with Alpha-1 Antitrypsin Deficiency (AATD)
Proof-of-mechanism data for WVE-006 in individuals with AATD remain on track for 2024CAMBRIDGE, Mass., April 30, 2024 -- Wave Life Sciences Ltd. , a clinical-stage biotechnology company focused on...
Source: marketscreener.com
Wave Life Sciences Announces Approval of First Clinical Trial Application for RestorAATion-2 ...
CAMBRIDGE, Mass., April 30, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human
Source: eagletribune.com
Wave Life Sciences Announces Continued Momentum in GSK Collaboration and Advancements in siRNA and RNA Editing
GSK has selected the first two programs to advance following achievement of target validation, marking transition to next phase of research collaboration; programs utilize Wave’s next generation...
Source: marketscreener.com